Cellestis Valuation Matrix
Assumes 60% Gross Profit Margin
Number of Tests - in millions
Single 10m 20m 30m 40m 50m
Test
$ $m $m $m $m $m
1. Sell Price per Test ($US) 15.00 15.00 15.00 15.00 15.00 15.00
Annual Sales Value ($US) 15.00 150.00 300.00 450.00 600.00 750.00
2. Annual Sales Value ($A) 0.75 20.00 200.00 400.00 600.00 800.00 1000.00
3. Cost of Goods Sold 40% (8.00) (80.00) (160.00) (240.00) (320.00) (400.00)
4. Gross Profit Margin 60% 12.00 120.00 240.00 360.00 480.00 600.00
5. Distributor Margin 15.0% (3.00) (30.00) (60.00) (90.00) (120.00) (150.00)
6. Overheads - (10.00) (10.00) (10.00) (10.00) (10.00)
Net Profit 9.00 80.00 170.00 260.00 350.00 440.00
Tax Rate 30.0% (2.70) (24.00) (51.00) (78.00) (105.00) (132.00)
NPAT 6.30 56.00 119.00 182.00 245.00 308.00
NPAT (as % of sales) 31.5% 27.8% 29.6% 30.3% 30.6% 30.8%
7. Quantiferon Platform Profits ? ? ? ? ?
8. Shares & Options (m) 96.43 - 96.43 96.43 96.43 96.43 96.43
Earnings Per Share $ - 0.58 1.23 1.89 2.54 3.19
P/E Ratio 20 - 20 20 20 20 20
Share Value $ - $11.62 $24.68 $37.75 $50.82 $63.88
- Forums
- ASX - By Stock
- CST
- lodge
CST
castile resources ltd
Add to My Watchlist
0.00%
!
5.6¢

lodge, page-14
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.12M |
Open | High | Low | Value | Volume |
5.9¢ | 5.9¢ | 5.4¢ | $76.73K | 1.378M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 636 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.054 |
3 | 276416 | 0.053 |
2 | 58843 | 0.051 |
2 | 70019 | 0.050 |
1 | 38173 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 636 | 1 |
0.060 | 40000 | 1 |
0.061 | 18711 | 1 |
0.067 | 200000 | 1 |
0.069 | 17154 | 1 |
Last trade - 15.54pm 27/06/2025 (20 minute delay) ? |
Featured News
CST (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online